Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Vertex Pharmaceuticals Inc. closed 10.71% below its 52-week high of $519.88, which the company reached on November 8th.

Vertex Pharmaceuticals Inc. closed 10.89% short of its 52-week high of $519.88, which the company achieved on November 8th.

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Vertex Pharmaceuticals (VRTX) closed at $469.55 in the latest trading session, marking a +1.15% move from the prior day.

Vertex Pharmaceuticals (VRTX) experienced a 4% price increase over the past month, coinciding with crucial developments in their portfolio. The recent advancement with NHS England's reimbursement ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $492.69, indicating a -1.96% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...

Vertex Pharmaceuticals Incorporated VRTX enjoys a dominant position in the cystic fibrosis (CF) market. ... Vertex’s stock has risen 15.9% against the industry’s 2.4% decline.

Additionally, shares of Vertex Pharmaceuticals have surged 14.7% over the past 52 weeks, while the IYH has improved nearly 1.2% in the same period. VRTX has mostly been trading above its 200-day ...

Vertex Pharmaceuticals' acquisition of Alpine Immune Sciences has the potential to boost their value and ... 2024 5:08 AM ET Vertex Pharmaceuticals Incorporated (VRTX) Stock ALPN, VRTX 4 Comments ...